Global Clinical Trial Management Services

PRA offers a full range of clinical drug development services in over 85 countries world wide (click on above map for more information).

We have a successful track record of managing programs in all phases of clinical development. In Phase I-IIa, we conduct studies in healthy volunteers as well as patient populations with specific medical conditions. PRA distinguishes itself by having mobile Phase I units and facilities inside hospitals to allow rapid recruitment of patients and volunteers. In Phase II-III, PRA has executed many pivotal trials that led to FDA and/or international regulatory approval. In late phase, we assist clients with the post-approval process by planning and conducting large, simple studies, registries, outcome studies, and risk management programs.

Our comprehensive services include:

Phase I-IIa

Phase II-III

Post Approval

Safety & Risk Management

Therapeutic Expertise